Stanford Cancer Center Emeryville — Emeryville, California

Stanford Cancer Center Emeryville is a clinical research site located in Emeryville, California, United States 94608.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Stanford Cancer Center Emeryville has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.

Sponsors: NRG Oncology, Alliance for Clinical Trials in Oncology, PrECOG, LLC..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Center Emeryville?

Stanford Cancer Center Emeryville has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Center Emeryville conducted?

Stanford Cancer Center Emeryville has 5 clinical trials on record, with 4 currently active. Their work covers Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, FIGO Stage III Ovarian Cancer 2014.

Is Stanford Cancer Center Emeryville accredited by Crixeo Health?

Yes — Stanford Cancer Center Emeryville holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Stanford Cancer Center Emeryville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.